MISX
MGNZ
Market cap34mUSD
Nov 07, Last price
7,440.00RUB
Name
Solikamskiy Magniyevyi Zavod OAO
Chart & performance
P/E
—
P/S
0.26
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
6.78%
Revenues
11.21b
-9.61%
Net income
-1.14b
L
CFO
-1.79b
L
Dividend
Jul 01, 2019150 RUB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Open joint stock company Solikamsk Magnesium Works is a key producer and international supplier of magnesium, chemical solutions, and rare metal products, serving high-tech industries both domestically in Russia and across international markets. Its magnesium product line includes pure and alloy magnesium metals, carnallite, calcium hypochlorite solution, and various fluxes. Additionally, the company delivers chemical products such as anhydrous magnesium chloride, calcium chloride solution, liquid chlorine, lime, lime milk, and calcium strontium carbonate. Its rare metals segment offers carbonates and oxides of rare earths; chemical concentrates, pentachlorides, and pentoxides of niobium and tantalum; titanium sponge and tetrachloride; and specialized rare earth compounds and lithium niobates. Founded in 1936, this Solikamsk, Russia-based entity has a long operational history.
Key people
Pavel Detkov
Independent Chairman of the Board · since 2018
Sergey Shalaev
Deputy Chairman of the Board · since 2015
Elena Remeslova
Chief Accountant
Anastasiya Zalazaeva
Head of the Corporate Relations Division · since 2014
Olga Lesnikova
Secretary to the Board of Directors · since 2019
Aleksey Butenko
Director · since 2016
Aleksey Chervonykh
Director · since 2014
Dmitry Kargapoltsev
Director · since 2019
Dmitry Melnikov
Director, General Director (CEO), Chief Engineer · since 2015
Artem Nechaev
Director · since 2019
Aleksey Pykhteev
Director · since 2012
Ivan Shatrov
Director, Deputy General Director of Development · since 2015
Timur Starostin
Director · since 2016
Aleksandr Lemyagov
Independent Director · since 2018
Yury Savin
Independent Director · since 2018
Valuation
Title RUB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||